215 related articles for article (PubMed ID: 20881488)
1. Anticoagulation of malignant glioma patients in the era of novel antiangiogenic agents.
Perry JR
Curr Opin Neurol; 2010 Dec; 23(6):592-6. PubMed ID: 20881488
[TBL] [Abstract][Full Text] [Related]
2. Venous thrombosis in patients with high-grade glioma.
Taillibert S; Taillandier L; Le Rhun E
Curr Opin Oncol; 2015 Nov; 27(6):516-21. PubMed ID: 26447877
[TBL] [Abstract][Full Text] [Related]
3. Complications from vascular disrupting agents and angiogenesis inhibitors: aberrant control of hemostasis and thrombosis.
van Heeckeren WJ; Sanborn SL; Narayan A; Cooney MM; McCrae KR; Schmaier AH; Remick SC
Curr Opin Hematol; 2007 Sep; 14(5):468-80. PubMed ID: 17934353
[TBL] [Abstract][Full Text] [Related]
4. Primary venous thromboembolism prophylaxis in ambulatory cancer patients.
Aikens GB; Rivey MP; Hansen CJ
Ann Pharmacother; 2013 Feb; 47(2):198-209. PubMed ID: 23386067
[TBL] [Abstract][Full Text] [Related]
5. Re: angiogenesis and antiangiogenic therapy for malignant gliomas.
Kepes JJ
Brain Tumor Pathol; 2005; 22(1):51. PubMed ID: 18095105
[No Abstract] [Full Text] [Related]
6. Subcutaneous heparin for prophylaxis of venous thromboembolism in deep brain stimulation surgery: evidence from a decision analysis.
Bauman JA; Church E; Halpern CH; Danish SF; Zaghloul KA; Jaggi JL; Stein SC; Baltuch GH
Neurosurgery; 2009 Aug; 65(2):276-80; discussion 280. PubMed ID: 19625905
[TBL] [Abstract][Full Text] [Related]
7. New and old anticoagulants in cancer.
Verso M; Agnelli G
Thromb Res; 2012 Apr; 129 Suppl 1():S101-5. PubMed ID: 22682118
[TBL] [Abstract][Full Text] [Related]
8. Safety of concurrent bevacizumab therapy and anticoagulation in glioma patients.
Norden AD; Bartolomeo J; Tanaka S; Drappatz J; Ciampa AS; Doherty LM; Lafrankie DC; Ruland S; Quant EC; Beroukhim R; Wen PY
J Neurooncol; 2012 Jan; 106(1):121-5. PubMed ID: 21706358
[TBL] [Abstract][Full Text] [Related]
9. Thrombosis in brain tumors.
Jo JT; Schiff D; Perry JR
Semin Thromb Hemost; 2014 Apr; 40(3):325-31. PubMed ID: 24599439
[TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism in patients with advanced cancer under palliative care: additional risk factors, primary/secondary prophylaxis and complications observed under normal clinical practice.
Soto-Cárdenas MJ; Pelayo-García G; Rodríguez-Camacho A; Segura-Fernández E; Mogollo-Galván A; Giron-Gonzalez JA
Palliat Med; 2008 Dec; 22(8):965-8. PubMed ID: 18952751
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism: a clinical review.
Osinbowale O; Ali L; Chi YW
Postgrad Med; 2010 Mar; 122(2):54-65. PubMed ID: 20203456
[TBL] [Abstract][Full Text] [Related]
12. Thromboprophylaxis in non-surgical cancer patients.
Cohen AT; Gurwith MM; Dobromirski M
Thromb Res; 2012 Apr; 129 Suppl 1():S137-45. PubMed ID: 22682125
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of angiogenesis and invasion in malignant gliomas.
Chi A; Norden AD; Wen PY
Expert Rev Anticancer Ther; 2007 Nov; 7(11):1537-60. PubMed ID: 18020923
[TBL] [Abstract][Full Text] [Related]
14. Low molecular weight heparin administration in cancer patients with hypercoagulability-related complications and carrying brain metastases: a case series study.
Vitale FV; Rotondo S; Sessa E; Parisi A; Giaimo V; D'Angelo A; Antonelli G; Romeo P; Ferraù F
J Oncol Pharm Pract; 2012 Mar; 18(1):10-6. PubMed ID: 21228085
[TBL] [Abstract][Full Text] [Related]
15. Duration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long term.
de Jong PG; Coppens M; Middeldorp S
Br J Haematol; 2012 Aug; 158(4):433-41. PubMed ID: 22734929
[TBL] [Abstract][Full Text] [Related]
16. [Optimal duration of anticoagulation of venous thromboembolism].
Savina EN; Couturaud F
J Mal Vasc; 2011 Dec; 36 Suppl 1():S28-32. PubMed ID: 22177766
[TBL] [Abstract][Full Text] [Related]
17. Role of palliative low-molecular-weight heparin for treating venous thromboembolism in patients with advanced cancer.
Tran QN
Am J Hosp Palliat Care; 2010 Sep; 27(6):416-9. PubMed ID: 20197558
[TBL] [Abstract][Full Text] [Related]
18. Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer.
Agnelli G; George DJ; Kakkar AK; Fisher W; Lassen MR; Mismetti P; Mouret P; Chaudhari U; Lawson F; Turpie AG;
N Engl J Med; 2012 Feb; 366(7):601-9. PubMed ID: 22335737
[TBL] [Abstract][Full Text] [Related]
19. The treatment of venous thromboembolism in patients with cancer.
Prandoni P
Intern Emerg Med; 2010 Oct; 5 Suppl 1():S27-30. PubMed ID: 20865471
[TBL] [Abstract][Full Text] [Related]
20. Treatment and secondary prevention of venous thromboembolism in cancer patients. Current strategies and new therapeutic options.
Ay C; Pabinger I
Hamostaseologie; 2012; 32(2):139-44. PubMed ID: 21822525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]